- Home
- App-Analyse
- DRUGDOCS
- DRUGDOCS Vs. Biosimilar
DRUGDOCS im Vergleich zu Biosimilar Nutzung und Statistiken
DRUGDOCS® provides health professionals with current, evidence-based information on the drugs they prescribe with direct access to publications.
- Apple App Store
- Kostenlos
- Medizin
Rang speichern
- -
Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics.
** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
- Apple App Store
- Bezahlt
- Medizin
Rang speichern
- -
DRUGDOCSvs. Biosimilar Ranking-Vergleich
Vergleichen Sie DRUGDOCS den Ranking-Trend der letzten 28 Tage mit Biosimilar
Biosimilar#132
Rang
DRUGDOCS im Vergleich zu Biosimilar Ranking im Ländervergleich
Vergleichen Sie DRUGDOCS den Ranking-Trend der letzten 28 Tage mit Biosimilar
Alle Kategorien
Keine Daten verfügbar
Medizin
Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an
DRUGDOCS VS.
Biosimilar
Dezember 19, 2024